ArticleCurrent pharmaceutical biotechnology2019

Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.

Marcin Oplawski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.